🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this trial is to assess the safety and efficacy of 24-week...
Status
Terminated
Location
511.156.01059 Boehringer Ingelheim Investigational Site
Start Date
2010-01
Trial ID
NCT01057901
Treatments Being Tested
The purpose of this study is to determine if the study drug will increase s...
Status
Terminated
Location
Baylor College of Medicine
Start Date
2020-05-08
Trial ID
NCT04002661
Treatments Being Tested
This is a double-blinded, placebo-controlled randomized phase II clinical t...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2021-07-02
Trial ID
NCT04743934
Treatments Being Tested
The object of this trial is to assess the safety and efficacy of a 24 week ...
Status
Completed
Location
511.147.01074 Boehringer Ingelheim Investigational Site
Start Date
2009-10
Trial ID
NCT00996164
Treatments Being Tested
An open label randomized, single dose, two-way crossover bioequivalence stu...
Status
Completed
Location
Genuine Research Center GRC
Start Date
2018-12-12
Trial ID
NCT04494191
Treatments Being Tested
The current trial will explore the safety of flibanserin in combination wit...
Status
Terminated
Location
Clinical Innovations
Start Date
2010-01
Trial ID
NCT01040208
Treatments Being Tested
The objective of this trial is to assess the safety and efficacy of 24-week...
Status
Completed
Location
511.130.01074 Boehringer Ingelheim Investigational Site
Start Date
2009-10
Trial ID
NCT00996372
Treatments Being Tested